JP2024538791A5 - - Google Patents
Info
- Publication number
- JP2024538791A5 JP2024538791A5 JP2024522375A JP2024522375A JP2024538791A5 JP 2024538791 A5 JP2024538791 A5 JP 2024538791A5 JP 2024522375 A JP2024522375 A JP 2024522375A JP 2024522375 A JP2024522375 A JP 2024522375A JP 2024538791 A5 JP2024538791 A5 JP 2024538791A5
- Authority
- JP
- Japan
- Prior art keywords
- ige
- antibody
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254729P | 2021-10-12 | 2021-10-12 | |
| US63/254,729 | 2021-10-12 | ||
| PCT/CN2022/124777 WO2023061390A1 (en) | 2021-10-12 | 2022-10-12 | Treatment of ige-mediated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538791A JP2024538791A (ja) | 2024-10-23 |
| JP2024538791A5 true JP2024538791A5 (https=) | 2025-10-20 |
Family
ID=85981469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522375A Pending JP2024538791A (ja) | 2021-10-12 | 2022-10-12 | ＩｇＥ介在性疾患の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230122862A1 (https=) |
| EP (1) | EP4416176A4 (https=) |
| JP (1) | JP2024538791A (https=) |
| KR (1) | KR20240082392A (https=) |
| CN (1) | CN118119641A (https=) |
| TW (1) | TW202332691A (https=) |
| WO (1) | WO2023061390A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024050455A2 (en) * | 2022-08-31 | 2024-03-07 | Heitmeyer Jamie Nicole | Anti-rhd antibodies for treating inflammatory dermal condition |
| WO2025015286A2 (en) * | 2023-07-13 | 2025-01-16 | Inhibrx Biosciences, Inc. | Ige binding proteins and uses thereof |
| KR20260042217A (ko) | 2023-07-13 | 2026-03-30 | 인히브릭스 바이오사이언스, 인크. | IgE 결합 단백질 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012204078A1 (en) * | 2007-02-15 | 2012-08-02 | Astrazeneca Ab | Binding members for IgE molecules |
| KR20140119777A (ko) * | 2012-01-31 | 2014-10-10 | 제넨테크, 인크. | 항-ig-e m1'' 항체 및 그의 사용 방법 |
| DK3157951T3 (da) * | 2014-06-17 | 2020-08-17 | Academia Sinica | Humaniserede anti-ige-antistoffer, der tværbinder cd23 på b-lymfocytter, men ikke sensibiliserer mastceller |
| JP6068582B2 (ja) * | 2015-08-07 | 2017-01-25 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | Ｂリンパ球上のヒトｍＩｇＥに結合可能な抗ＣεｍＸ抗体 |
| GB201610198D0 (en) * | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
| WO2019085902A1 (en) * | 2017-10-31 | 2019-05-09 | Fountain Biopharma Inc. | Treating ige-mediated allergic diseases |
-
2022
- 2022-10-12 JP JP2024522375A patent/JP2024538791A/ja active Pending
- 2022-10-12 WO PCT/CN2022/124777 patent/WO2023061390A1/en not_active Ceased
- 2022-10-12 TW TW111138537A patent/TW202332691A/zh unknown
- 2022-10-12 CN CN202280068465.3A patent/CN118119641A/zh active Pending
- 2022-10-12 US US17/964,101 patent/US20230122862A1/en active Pending
- 2022-10-12 KR KR1020247014489A patent/KR20240082392A/ko active Pending
- 2022-10-12 EP EP22880326.8A patent/EP4416176A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024538791A5 (https=) | ||
| JP6271631B2 (ja) | 種々の疾患の治療のための抗−ｎｇｆ抗体 | |
| Vichyanond | Omalizumab in allergic diseases, a recent review | |
| ES2701093T3 (es) | Métodos para tratar o prevenir el asma administrando un antagonista de IL-4R | |
| JP2020516647A5 (https=) | ||
| JP2004536072A5 (https=) | ||
| CA2656620A1 (en) | Cd20 binding molecules for the treatment of copd | |
| JP2024502471A (ja) | ピーナッツアレルギーを治療するための方法およびｉｌ－４ｒアンタゴニストを投与することによってピーナッツアレルゲン特異的免疫療法を増強する方法 | |
| CN111372948A (zh) | 用il-17拮抗剂治疗化脓性汗腺炎 | |
| KR20140061403A (ko) | 항―ｉｌ―１３ 항체를 이용하여 천식을 치료하기 위한 방법 및 조성물 | |
| WO2021255621A1 (en) | Treatment of food allergy using anti-ige antibodies | |
| JP2024544380A (ja) | 抗ＩｇＥ抗体を使用したアレルギー反応の治療 | |
| TW202332691A (zh) | Ige調節的疾病的治療 | |
| JP2021523881A (ja) | リゲリズマブを使用して慢性特発性蕁麻疹を治療する方法 | |
| JP2023505215A (ja) | Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法 | |
| AU2021293980B2 (en) | Treatment of food allergy using anti-IgE antibodies | |
| CA3062179A1 (en) | Methods of selectively treating asthma using il-17 antagonists | |
| CN109641053A (zh) | 给药方案 | |
| RU2854872C1 (ru) | Лечение аллергии на пищевые продукты с применением антител к ige | |
| JP7216157B2 (ja) | Ｉｌ－４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 | |
| JP2013119531A (ja) | Ｈｔｌｖ−１関連脊髄症を治療または予防するための医薬および前記医薬を用いた抗体療法の治療効果の確認方法 | |
| CN116887858A (zh) | 通过施用il-4r拮抗剂治疗花生过敏并增强花生过敏原特异性免疫疗法的方法 | |
| BR122019023269B1 (pt) | composição farmacêutica compreendendo um anticorpo que se liga especificamente ao receptor da interleucina-4 (il-4r) para uso no tratamento de asma moderada a grave ou grave em um indivíduo |